SEARCH

SEARCH BY CITATION

References

  • ACDP (2011a) Assessment to be carried out before surgery and/or endoscopy to identify patients with, or at increased risk of, CJD or vCJD. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_123586.pdf accessed March 2012
  • ACDP (2011b) Part 4 Infection control of CJD, vCJD and other human prion diseases in healthcare and community settings. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_129681.pdf accessed March 2012
  • ACDP (2011c) Annexe F Endosopy. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_123588.pdf accessed March 2012
  • AFSSAPS (2003) Analysis of the Risk of Variant Creutzfeldt-Jakob Disease Transmssion by Medicinal Products of Human Origin and Labile Blood Products. http://www.afssaps.fr/var/afssaps_site/storage/original/application/ddfbeeeaef904b1c0dec1e70f4f27570.pdf Agence française de sécurité sanitaire des produits de santé, Paris. accessed March 2012
  • Bishop, M.T. , Hart, P. , Aitchison, L. , Baybutt, H.N. , Plinston, C. , Thomson, V. , Tuzi, N.L. , Head, M.W. , Ironside, J.W. , Will, R.G. & Manson, J.C. (2006) Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurology, 5, 393398.
  • Boelle, P.Y. , Cesbron, J.Y. & Valleron, A.J. (2004) Epidemiological evidence of higher susceptibility to vCJD in the young. BioMedCentral Infectious Diseases, 4, 26.
  • Brown, P. (2000) BSE and transmission through blood. Lancet, 356, 955956.
  • Brown, P. , Rohwer, R.G. , Dunstan, B.C. , MacAuley, C. , Gajdusek, D.C. & Drohan, W.N. (1998) The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion, 38, 810816.
  • Brown, P. , Cervenáková, L. , McShane, L.M. , Barber, P. , Rubenstein, R. & Drohan, W.N. (1999) Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion, 39, 11691178.
  • Brown, K.L. , Wathne, G.J. , Sales, J. , Bruce, M.E. & Mabbott, N.A. (2009) The effects of host age on follicular dendritic cell status dramatically impair scrapie agent neuroinvasion in aged mice. Journal of Immunology, 183, 51995207.
  • Bruce, M.E. , Will, R.G. , Ironside, J.W. , McConnell, I. , Drummond, D. , Suttie, A. , McCardle, L. , Chree, A. , Hope, J. , Birkett, C. , Cousens, S. , Fraser, H. & Bostock, C.J. (1997) Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature, 389, 498501.
  • CJDIP (2004a) Management of possible exposure to CJD through medical procedures. http://www.hpa.org.uk/servlet/ContentServer?c=HPAweb_C&cid=1194947314514&pagename=HPAwebFile accessed March 2012
  • CJDIP (2004b) Assessment of exposure to particular batches of variant Creutzfeldt-Jakob disease (vCJD) implicated plasma products. http://www.wfh.org/2/docs/Safety_Supply/vCJD_Incidents_panel.pdf> accessed March 2012
  • Clarke, P. & Ghani, A.C. (2005) Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility. Journal of the Royal Society, Interface, 2, 1931.
  • Clewley, J.P. , Kelly, C.M. , Andrews, N. , Vogliqi, K. , Mallinson, G. , Kaisar, M. , Hilton, D.A. , Ironside, J.W. , Edwards, P. , McCardle, L.M. , Ritchie, D.L. , Dabaghian, R. , Ambrose, H.E. & Gill, O.N. (2009) Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ, 338, b1442.
  • Collinge, J. (2001) Prion diseases of humans and animals: their causes and molecular basis. Annual Review of Neuroscience, 24, 519550.
  • Collinge, J. , Whitfield, J. , McKintosh, E. , Beck, J. , Mead, S. , Thomas, D.J. & Alpers, M.P. (2006) Kuru in the 21st century–an acquired human prion disease with very long incubation periods. Lancet, 367, 20682074.
  • Comer, P. & Spouge, J. . (1999) Assessment of the risk of exposure to vCJD infectivity in blood and blood products. Det Norske Veritas Final Report, Job No. 8288. Det Norske Veritas, London, UK.
  • Cousens, S.N. , Vynnycky, E. , Zeidler, M. , Will, R.G. & Smith, P.G. (1997) Predicting the CJD epidemic in humans. Nature, 385, 197198.
  • CPMP (1998) Position statement on new variant CJD and plasma-derived medicinal products. European Agency for the Evaluation of Medicinal Products, London.
  • DH (2001) Risk assessment for transmission of vCJD via Surgical Instruments: A modelling approach and numerical scenarios. Department of Health, UK.
  • DNV (2003). Risk Assessment of Exposure to vCJD Infectivity in Blood and Blood Products. Report for UK Department of Health. Det Norske Veritas Report no. 716108 Rev D (Final) 24 February 2003. Det Norske Veritas, London, UK.
  • Edgeworth, J.A. , Jackson, G.S. , Clarke, A.R. , Weissmann, C. & Collinge, J. (2009) Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces. Proceedings of the National Academy of Sciences of the United States of America, 106, 34793483.
  • Edgeworth, J.A. , Farmer, M. , Sicilia, A. , Tavares, P. , Beck, J. , Campbell, T. , Lowe, J. , Mead, S. , Rudge, P. , Collinge, J. & Jackson, G.S. (2011) Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet, 377, 487493.
  • FDA (2006) Draft quantitative risk assessment of vCJD risk potentially associated with the use of human plasma-derived factor VIII manufactured under United States license from plasma collected in the US. http:/www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/BloodSafety/UCM095104,pdf. US Food and Drug Administration, Center for Biologics Evaluation and Research. accessed March 2012
  • Foster, P.R. (1999) Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy. Transfusion Medicine (Oxford, England), 9, 314.
  • Foster, P.R. , Welch, A.G. , McLean, C. , Griffin, B.D. , Hardy, J.C. , Bartley, A. , MacDonald, S. & Bailey, A.C. (2000) Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products. Vox Sanguinis, 78, 8695.
  • Foster, P.R. , Griffin, B.D. , Bienek, C. , McIntosh, R.V. , MacGregor, I.R. , Somerville, R.A. , Steele, P.J. & Reichl, H.E. (2004) Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII. Vox Sanguinis, 86, 9299.
  • Garske, T. & Ghani, A.C. (2010) Uncertainty in the Tail of the variant Creutzfledt Jakob disease epidemic in the UK. PLoS ONE, 5, e15626.
  • Ghani, A.C. , Ferguson, N.M. , Donnelly, C.A. , Hagenaars, T.J. & Anderson, R.M. (1998) Estimation of the number of people incubating variant CJD. Lancet, 352, 13531354.
  • Ghani, A.C. , Donnelly, C.A. , Ferguson, N.M. & Anderson, R.M. (2003) Updated projections of future vCJD deaths in the UK. BioMedCentral Infectious Diseases, 3, 4.
  • Head, M.W. , Ritchie, D. , Smith, N. , McLoughlin, V. , Nailon, W. , Samad, S. , Masson, S. , Bishop, M. , McCardle, L. & Ironside, J.W. (2004) Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. American Journal of Pathology, 164, 143153.
  • Hewitt, P.E. , Llewelyn, C.A. , Mackenzie, J. & Will, R.G. (2006) Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review Study. Vox Sanguinis, 91, 221230.
  • Hill, A.F. , Joiner, S. , Linehan, J. , Desbruslais, M. , Lantos, P.L. & Collinge, J. (2000) Species-barrier-independent prion replication in apparently resistant species. Proceedings of the National Academy of Sciences of the United States of America, 97, 1024810253.
  • Hilton, D.A. , Ghani, A.C. , Conyers, L. , Edwards, P. , McCardle, L. , Ritchie, D. , Penney, M. , Hegazy, D. & Ironside, J.W. (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. Journal of Pathology, 203, 733739.
  • Holada, K. , Vostal, J.G. , Theisen, P.W. , MacAuley, C. , Gregori, L. & Rohwer, R.G. (2002) Scrapie infectivity in hamster blood is not associated with platelets. Journal of Virology, 76, 46494650.
  • Houston, F. , Foster, J.D. , Chong, A. , Hunter, N. & Bostock, C.J. (2000) Transmission of BSE by blood transfusion in sheep. Lancet, 356, 9991000.
  • HPA (2006) New case of transfusion-associated variant CJD. The Communicable Disease Report Weekly, 16(16), 11.
  • HPA (2011) Health Protection Report. www.hpa.org.uk/hpr/archives/2011/news3611.htm, United Kingdom.
  • Hunter, N. , Foster, J. , Chong, A. , McCutcheon, S. , Parnham, D. , Eaton, S. , MacKenzie, C. & Houston, F. (2002) Transmission of prion diseases by blood transfusion. Journal of General Virology, 83, 28972905.
  • Kaski, D. , Mead, S. , Hyare, H. , Cooper, S. , Jampana, R. , Overell, J. , Knight, R. & Collinge, J. (2009) Variant CJD in an individual heterozygous for PRNP codon 129. The Lancet, 374, 2128.
  • Llewelyn, C.A. , Hewitt, P.E. , Knight, R.S. , Amar, K. , Cousens, S. , Mackenzie, J. & Will, R.G. (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet, 363, 417421.
  • McGowan, C.R. & Viens, A.M. (2011) Coroners and the obligation to protect public health: the case of the failed UK vCJD study. Public Health, 125, 234237.
  • Millar, C.M. , Connor, N. , Dolan, G. , Lee, C.A. , Makris, M. , Wilde, J. , Winter, M. , Ironside, J.W. , Gill, N. & Hill, F.G. (2010) Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders. Haemophilia, 16, 305315.
  • NCJDSU (2012) CJD Statistics. The National Creutzfeldt-Jakob Disease Surveillance Unit www.cjd.ed.ac.uk/figures.htm, Edinburgh. accessed March 2012
  • Pastrana, M.A. , Sajnani, G. , Onisko, B. , Castilla, J. , Morales, R. , Soto, C. & Requena, J.R. (2006) Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry, 45, 1571015717.
  • Peden, A.H. , Head, M.W. , Ritchie, D.L. , Bell, J.E. & Ironside, J.W. (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet, 364, 527529.
  • Peden, A. , McCardle, L. , Head, M.W. , Love, S. , Ward, H.J. , Cousens, S.N. , Keeling, D.M. , Millar, C.M. , Hill, F.G. & Ironside, J.W. (2010) Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia, 16, 296304.
  • Reichl, H.E. , Foster P.R., Welch.A.G. , Li Q., Mac.Gregor.I.R. , Somerville R.A., Fernie.K. & Steele P.J, Taylor.D.M. (2002) Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin. Vox Sanguinis, 83, 137145.
  • Scott, M.R. , Will, R. , Ironside, J. , Nguyen, H.O. , Tremblay, P. , DeArmond, S.J. & Prusiner, S.B. (1999) Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proceedings of the National Academy of Sciences of the United States of America, 96, 1513715142.
  • SEAC (2006a) SEAC Epidemiology Subgroup position statement on the vCJD epidemic. Spongiform Encephalopathy Advisory Committee, London.
  • SEAC (2006b) Position statement on TSE infectivity in blood. Vol. 2006. http://webarchive.nationalarchives.gov.uk/20110316162913/http://www.seac.gov.uk/statements/statement0806.htm. accessed May 2012
  • Silveira, J.R. , Raymond, G.J. , Hughson, A.G. , Race, R.E. , Sim, V.L. , Hayes, S.F. & Caughey, B. (2005) The most infectious prion protein particles. Nature, 437, 257261.
  • St Rose, S.G. , Hunter, N. , Matthews, L. , Foster, J.D. , Chase-Topping, M.E. , Kruuk, L.E. , Shaw, D.J. , Rhind, S.M. , Will, R.G. & Woolhouse, M.E. (2006) Comparative evidence for a link between Peyer's patch development and susceptibility to transmissible spongiform encephalopathies. BMC Infectious Diseases, 6, 5.
  • Swerdlow, A.J. , Higgins, C.D. , Adlard, P. , Jones, M.E. & Preece, M.A. (2003) Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology, 61, 783791.
  • Truchot, L. , Arnaud, T. , Bloy, C. & Perret-Liaudet, A. (2006) CJD PrPsc removal by nanofiltration process: application to a therapeutic immunoglobulin solution (Lymphoglobuline). Biologicals, 34, 227231.
  • UKHCDO (1997) Guidelines on therapeutic products to treat haemophilia and other hereditary coagulation disorders. Haemophilia, 3, 6377.
    Direct Link:
  • Wadsworth, J.D. , Joiner, S. , Hill, A.F. , Campbell, T.A. , Desbruslais, M. , Luthert, P.J. & Collinge, J. (2001) Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet, 358, 171180.
  • Wadsworth, J.D. , Joiner, S. , Linehan, J.M. , Asante, E.A. , Brandner, S. & Collinge, J. (2008) Review. The origin of the prion agent of kuru: molecular and biological strain typing. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 363, 37473753.
  • Will, R.G. , Ironside, J.W. , Zeidler, M. , Cousens, S.N. , Estibeiro, K. , Alperovitch, A. , Poser, S. , Pocchiari, M. , Hofman, A. & Smith, P.G. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet, 347, 921925.
  • Wroe, S.J. , Pal, S. , Siddique, D. , Hyare, H. , Macfarlane, R. , Joiner, S. , Linehan, J.M. , Brandner, S. , Wadsworth, J.D. , Hewitt, P. & Collinge, J. (2006) Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet, 368, 20612067.
  • Zaman, S.M. , Hill, F.G. , Palmer, B. , Millar, C.M. , Bone, A. , Molesworth, A.M. , Connor, N. , Lee, C.A. , Dolan, G. , Wilde, J.T. , Gill, O.N. & Makris, M. (2011) The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products. Haemophilia, 17, 931937.
  • Zobeley, E. , Flechsig, E. , Cozzio, A. , Enari, M. & Weissmann, C. (1999) Infectivity of scrapie prions bound to a stainless steel surface. Molecular Medicine, 5, 240243.